Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

Trump's pick to run the Department of Health and Human Services gave away the agenda -- and may have invited a strong legal ...

This new nonaddictive alternative is the first of its kind that interrupts the pain signal before it reaches the brain.

The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...

The official purpose of Robert F. Kennedy, Jr.'s marathon Senate confirmation hearings this week was for lawmakers to decide ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

U.S. federal officials have approved a new pain pill aimed at preventing addiction and overdose risks linked to opioids like ...

This neon green cocktail is a potent mix of spirits and melon liqueur, famously known as the “most powerful drink in New ...

It’s been six months since the state resumed control of the Lawrenceville Correctional Center. It was the only privately ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction ...